MyStroke for Stroke Survivors and Caregivers
An Individualized Video-based Stroke Education Platform for Stroke Survivors and Caregivers
1 other identifier
interventional
690
1 country
5
Brief Summary
The goal of this multicenter randomized trial is to evaluate the impact of a personalized video-based stroke education platform on patient-centered and health system-centered outcomes. The main questions this study aims to address are:
- 1.Does a personalized, video-based educational platform improve stroke knowledge?
- 2.Does a personalized, video-based educational platform reduce post-discharge health system utilization?
- 3.Do different strategies of nudging improve engagement with educational material after hospital discharge?
- 4.Receive standard education during the stroke hospitalization
- 5.Complete a survey on the day of hospital discharge to assess their baseline knowledge.
- 6.Half of the subjects will be randomly assigned to also receive access to the personalized stroke education platform on the day of discharge.
- 7.All subjects will complete two follow-up study visits (7 and 90 days after discharge) in order to complete surveys.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2024
CompletedFirst Posted
Study publicly available on registry
June 4, 2024
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2030
January 8, 2026
January 1, 2026
3.8 years
May 29, 2024
January 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Stroke Patient Education Retention (SPER) survey
Total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)
90 days
Secondary Outcomes (10)
Patient satisfaction with stroke education
90 days
Stroke etiology awareness
90 days
Stroke risk factor awareness
90 days
Antithrombotic medication awareness
90 days
Stroke Self-Efficacy Questionnaire (SSEQ)
90 days
- +5 more secondary outcomes
Other Outcomes (7)
The Stroke Patient Education Retention (SPER) survey (7 days)
7 days
Patient satisfaction with stroke education (7 days)
7 days
Stroke etiology awareness (7 days)
7 days
- +4 more other outcomes
Study Arms (2)
Standard stroke education
NO INTERVENTIONParticipants in this arm of the study will receive institutional standard stroke education during the course of the hospitalization, standardized across the 5 participating sites. Standard education consists of non-standardized verbal bedside education by the care team, a standardized stroke educational booklet, and standardized verbal instructions by the bedside nurse addressing stroke risk factors and medications.
MyStroke + standard stroke education
EXPERIMENTALParticipants in this arm of the study will receive institutional standard stroke education in addition to access to MyStroke, a personalized video-based education platform. Each participant will receive their personalized page via email or SMS, as per their preference, and they will receive automated nudges to visit educational material after hospital discharge.
Interventions
MyStroke is a video-based educational platform that curates brief educational videos to inform patients and caregivers about key aspects of their stroke. Upon registering a user, information regarding the patient's stroke etiology, relevant stroke risk factors, and stroke prevention medications are used to populate educational content that is relevant to the individual. Users receive automated nudges to revisit MyStroke after hospital discharge on day 1, 3, 5, 7, and weekly thereafter.
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Admitted to hospital with clinical diagnosis of acute ischemic stroke (imaging confirmation not required)
- Stroke symptom onset within 30 days of enrollment
- Being discharged to either home or an acute rehabilitation facility
- Access to internet enabled device (smartphone, tablet, computer)
- Fluent in either English or Spanish (does not need to be native or primary language)
- Willingness and ability to sign informed consent
You may not qualify if:
- Severe aphasia (score of ≥2 on NIHSS item 9)
- Ischemic stroke that is attributed to a surgical procedure
- Resides in a skilled nursing facility prior to admission
- Being discharged to skilled nursing facility or long-term acute care facility
- Unwillingness or inability to participate in remote/virtual study visits
- A terminal or advanced condition that raises the possibility the subject may not survive 90 days
- Any other illness or condition that the investigator feels would pose a hazard to the subject from participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
The Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Pennsylvania Hospital
Philadelphia, Pennsylvania, 19107, United States
Chester County Hospital
West Chester, Pennsylvania, 19380, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher G Favilla, MD
Assistant Professor of Neurology at the University of Pennsylvania
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Given the nature of the intervention (an educational platform), masking of participants is not feasible, but other key study members (and clinicians) will be blinded to the study assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Neurology at the University of Pennsylvania
Study Record Dates
First Submitted
May 29, 2024
First Posted
June 4, 2024
Study Start
March 1, 2026
Primary Completion (Estimated)
November 30, 2029
Study Completion (Estimated)
March 1, 2030
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- We anticipate final sharing of data will take place at the completion of the 5-year project, but if an interim analysis results in a publication, the dataset will be shared at that time-point.
- Access Criteria
- The data will be publicly available and searchable on figshare (figshare.com), and the availability of shared derived data will be described in publications and presentation.
Once a manuscript describing such data is accepted for publication, the deidentified dataset contributing to the publication will be shared publicly using the figshare repository (figshare.com). The availability of shared derived data will be described in publications and presentation.